[
  {
    "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 1 shows the flow of participants through the study.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows the percentage of opioid-positive urine samples provided by participants in the two groups during the study.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  }
]